Evidence summary
What the research actually says
44Evidence confidence
Early / limited human trials5 randomized controlled trials · 1 meta-analyses / systematic reviews
Limited human trials; moderate preclinical immune data; premium culinary value
Beta-glucan polysaccharides from matsutake show significant immunostimulatory effects in vitro and in animal models. Human evidence is limited — most clinical data comes from Japanese studies on matsutake as a cancer immunotherapy adjuvant. The primary value proposition today is as a premium functional food, not a high-dose supplement.
12registered clinical trials reference this intervention 2selected from 89+ PubMed papers (longevity / aging angle) Key active: Matsutake polysaccharides, 1-octen-3-ol, ergosterol.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-06-14. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.